
SillaJen seals Woosung merger, tapping IV drug sales to boost revenue
SillaJen has completed a small-scale absorption merger with Korea's Woosung Pharmaceutical, bringing the IV drug specialist fully under its roof to bolster revenue and expand its pharmaceutical operations. The 100 percent merger -- approved by SillaJen …